Q1 2024 SI-BONE Inc Earnings Call Transcript
Key Points
- SI-BONE Inc reported a strong first quarter with $37.9 million in worldwide revenue, marking a 16% growth year-over-year.
- The company achieved a record number of new physician trainings, enhancing its physician engagement and expanding its user base.
- SI-BONE Inc received FDA clearance for its 9.5mm diameter ICs, Bedrock branded implants, opening new market opportunities in pediatric deformity and other areas.
- The company celebrated a significant milestone of completing 100,000 procedures using its products, underscoring its market leadership and execution capabilities.
- SI-BONE Inc's strategic initiatives and product launches over the past years have successfully driven a 24% cumulative annual revenue growth and doubled its active physician base.
- Despite strong revenue growth, SI-BONE Inc reported a net loss of $10.9 million for the quarter, although this was a 2% improvement year-over-year.
- The company faces ongoing risks related to the ability to maintain favorable reimbursement for its products and procedures.
- There are challenges associated with potential economic weakness impacting patients' ability and desire to undergo elective procedures.
- SI-BONE Inc's operating expenses grew by 10% due to higher commissions, stock-based compensation, and research and development investments.
- The company must navigate risks related to supply chain management and the impact of future capital requirements driven by new product introductions.
Good afternoon and welcome to SI-BONE First Quarter 2024 earnings conference call. At this time, all participants are in listen only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Saqib Iqbal, Senior Director of Investor Relations at SI-BONE for a few introductory comments.
Thank you for participating in today's call. Joining me are Laura Francis, Chief Executive Officer; and Anshul Maheshwari, Chief Financial Officer. Earlier today, SI-BONE released financial results for the quarter ended March 31, 2024. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
